S2 Genomics will develop the Singulator™ system for automated preparation of single cells or nuclei from solid tissue samples LIVERMORE, Calif.--S2 Genomics, Inc. has received a $280,000 Phase I STTR grant (1 R41 HG010129-01) from the National Institutes of Health’s National Human Genome Research Institute to develop the Singulator™ system for automated preparation of single [...]

PISCATAWAY, NJ – HORIBA Scientific, a global leader in Raman, fluorescence, elemental analysis, forensics, GDS, ICP, particle characterization, ellipsometry, sulfur-in-oil, water quality, SPRi and XRF instrumentation and solutions, is proud to announce that it has moved to a new location in Piscataway, New Jersey. HORIBA’s continued growth necessitated the decision to move from its Edison, NJ location, [...]

Company to focus on Aviation, Power and Renewable Energy Healthcare to become standalone company; GE expects to monetize 20% and distribute remaining 80% of GE Healthcare to shareholders tax-free Plans to fully separate Baker Hughes, a GE company (BHGE) Strengthening the balance sheet: Clear path to reduce debt by $25 billion, achieve Industrial net debt [...]

Integrated circuits from AGH UST play integral role in Hybrid Pixel Array and Hybrid Photon Counting Detectors made by Rigaku Corporation – world leader in production of research equipment   Krakow Poland. X-ray analytical instrument manufacturer Rigaku Corporation is pleased to recognize its 10 year collaboration with AGH University of Science and Technology in Krakow, Poland. The university, whose scientists [...]

SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of David King as Vice President, Research and Development, Genomics. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, King will drive R&D strategy and execution for all genomics products and systems across the company. “Fluidigm is a leader in deep, high-parameter [...]

£1.6m investment recognises BioAscent’s unique capabilities   NEWHOUSE, UK: BioAscent Discovery Limited (www.bioascent.com) has secured £1.6m in funding from Maven Capital Partners (“Maven”). The investment will facilitate BioAscent’s growth through its unique offering of integrated drug discovery, and compound management services, as well as the Compound Cloud library of lead-like pharma compounds, from its state-of-the-art facility at BioCity, Scotland. This offering [...]

Queen's has opened a new laboratory in the School of Chemistry and Chemical Engineering, equipped with state-of-the-art instruments from leading analytical instrument manufacture company Agilent. Developed to maximise students' practical lab experience for the postgraduate course in Pharmaceutical Analysis, the new lab features 18 Agilent instruments from gas and liquid chromatographs and mass spectrometers to [...]

MINNEAPOLIS and WALTHAM, Mass. -- Bio-Techne Corporation (NASDAQ: TECH) announced today that it has reached agreement to acquire Exosome Diagnostics, Inc. for $250 million in cash plus contingent consideration of up to $325 million due upon the achievement of certain future milestones. The transaction is expected to close in July or early August 2018. The transaction will [...]

- Novel High-throughput NMR and MS Solutions for Translational Phenomics Research and Biobanking - NMR quantification of metabolites and lipoprotein subclass analysis now in one measurement SEATTLE -- At Metabolomics 2018 (metabolomics2018.org), Bruker today announced B.I.QUANT-PS™, a metabolite quantification solution on its AVANCE IVDr™ 600 MHz NMR platform, which brings cost-effective nuclear magnetic resonance (NMR) screening to high-throughput, [...]

Postnova Analytics report on how researchers from the Institute for Health and Consumer Protection at the European Commission Joint Research Centre (Ispra, Italy) and the University of Ferrara  have used AF2000 Asymmetric Flow Field Flow Fractionation (AF4) system and Model S101 Sedimentation Flow Field Fractionation (SdFFF) systems in some ground-breaking research. In the last 20 [...]